Clicky

Avantor, Inc.(AVTR)

Description: Avantor, Inc. develops, customizes, manufactures, and supplies products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, and process chromatography resins and columns, as well as analytical sample prep, education, and microbiology and clinical trial kits. Its equipment and instrumentation products comprise filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and environment supplies. The company also provides onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.


Keywords: Biology Silicone Microbiology Excipients Chromatography Filtration Systems Instrumentation Products Evaporator Excipient Applied Materials Freezers Analytical Instruments Lab Products

Home Page: www.avantorsciences.com

AVTR Technical Analysis

Radnor Corporate Center
Radnor, PA 19087
United States
Phone: 610 386 1700


Officers

Name Title
Mr. Michael Stubblefield Pres, CEO & Director
Mr. Thomas A. Szlosek Exec. VP & CFO
Dr. Gerard Brophy Ph.D. Exec. VP of Biopharma Production
Mr. Frederic Vanderhaegen Exec. VP of Europe
Ms. Sheri Lewis Exec. VP of Global Supply Chain
Mr. Steven W. Eck Sr. VP, Corp. Controller & Chief Accounting Officer
Mr. Michael Wondrasch Exec. VP & Chief Information Officer
Mr. Tommy J. Thomas CPA VP of Investor Relations
Mr. Justin M. Miller Esq. Exec. VP, Gen. Counsel & Sec.
Ms. Allison K. Hosak Sr. VP of Global Communications & Brand

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 14.7275
Trailing PE: 21.5208
Price-to-Book MRQ: 3.1086
Price-to-Sales TTM: 1.8869
IPO Date: 2019-05-17
Fiscal Year End: December
Full Time Employees: 13500
Back to stocks